🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  2. evorpacept

    ALX ONCOLOGY HOLDINGS INC

    Higher Risk Myelodysplastic Syndromes

    phase 1 small molecule terminated

    1 trial

  3. iloperidone (oral tablet)

    Vanda Pharmaceuticals Netherlands B.V.

    Safety and Tolerability of Iloperidone

    phase 1 small molecule completed

    1 trial

  4. intraconazole

    ENANTA PHARMACEUTICALS INC

    NASH - Nonalcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  5. iridoid enriched mixed fruit beverage

    International Peace Maternity and Child Health Hospital

    Oxidative Stress

    phase 1 other completed

    1 trial

  6. lumacaftor 200 mg q12h + ivacaftor 250 mg q12h

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  7. mPEG-r-crisantaspase

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Malignancies

    phase 1 mab completed

    1 trial

  8. medroxyprogesterone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  9. metformin hydrochloride 500 mg tablet

    PMV Pharmaceuticals

    TP53 Y220C Mutation

    phase 1 small molecule active

    1 trial

  10. mipomersen

    IONIS PHARMACEUTICALS INC

    Healthy Volunteer

    phase 1 small molecule completed

    3 trials

  11. mipomersen sodium

    IONIS PHARMACEUTICALS INC

    Healthy

    phase 1 small molecule completed

    1 trial

  12. new formulations of 611

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Atopic Dermatitis

    phase 1 small molecule active

    1 trial

  13. omacetaxine mepesuccinate

    Teva Pharma GmbH

    Hematologic Malignancies

    phase 1 small molecule completed

    1 trial

  14. paclitaxel cationic liposome for injection

    CSPC Baike (Shandong) Biopharmaceutical Co.,

    Colorectal Liver Metastases

    phase 1 small molecule active

    1 trial

  15. placebo

    Lakefront Biotherapeutics NV

    Healthy

    phase 1 small molecule completed

    1 trial

  16. placebo

    Innovent Biologics (Suzhou) Co.

    Healthy

    phase 1 mab completed

    1 trial

  17. placebo control

    Takeda

    Hemophilia

    phase 1 small molecule terminated

    1 trial

  18. pyroglutamate rongliflozin capsules

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  19. pyroglutamate rongliflozin capsules

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 small molecule completed

    1 trial

  20. randomized, double-blinded, placebo-controlled

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

  21. recombinant human thrombopoietin injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Liver Disease Chronic

    phase 1 small molecule active

    1 trial

  22. rilonacept (IL-1 Trap)

    Regeneron UK Limited

    Systemic Juvenile Idiopathic Arthritis

    phase 1 small molecule completed

    1 trial

  23. sD-NP-GT8 DNA

    INOVIO PHARMACEUTICALS, INC.

    HIV Infections

    phase 1 mab completed

    1 trial

  24. sabirnetug (ACU193)

    Acumen Pharmaceuticals

    Alzheimer Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources